Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.
Abassi L, Bertoglio F, Mačak Šafranko Ž, Schirrmann T, Greweling-Pils M, Seifert O, Khan F, Katzmarzyk M, Jacobsen H, Gödecke N, Heine PA, Frenzel A, Nowack H, Dübel S, Kurolt IC, Kontermann RE, Markotić A, Schubert M, Hust M, Čičin-Šain L. Abassi L, et al. Among authors: godecke n. Viruses. 2023 Oct 25;15(11):2153. doi: 10.3390/v15112153. Viruses. 2023. PMID: 38005829 Free PMC article.
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
Zoodsma M, de Nooijer AH, Grondman I, Gupta MK, Bonifacius A, Koeken VACM, Kooistra E, Kilic G, Bulut O, Gödecke N, Janssen N, Kox M, Domínguez-Andrés J, van Gammeren AJ, Ermens AAM, van der Ven AJAM, Pickkers P, Blasczyk R, Behrens GMN, van de Veerdonk FL, Joosten LAB, Xu CJ, Eiz-Vesper B, Netea MG, Li Y. Zoodsma M, et al. Among authors: godecke n. Front Immunol. 2022 Nov 3;13:1027122. doi: 10.3389/fimmu.2022.1027122. eCollection 2022. Front Immunol. 2022. PMID: 36405747 Free PMC article.
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.
Bonifacius A, Tischer-Zimmermann S, Santamorena MM, Mausberg P, Schenk J, Koch S, Barnstorf-Brandes J, Gödecke N, Martens J, Goudeva L, Verboom M, Wittig J, Maecker-Kolhoff B, Baurmann H, Clark C, Brauns O, Simon M, Lang P, Cornely OA, Hallek M, Blasczyk R, Seiferling D, Köhler P, Eiz-Vesper B. Bonifacius A, et al. Among authors: godecke n. Front Bioeng Biotechnol. 2022 Apr 4;10:867042. doi: 10.3389/fbioe.2022.867042. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35480981 Free PMC article.
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Gussarow D, Bonifacius A, Cossmann A, Stankov MV, Mausberg P, Tischer-Zimmermann S, Gödecke N, Kalinke U, Behrens GMN, Blasczyk R, Eiz-Vesper B. Gussarow D, et al. Among authors: godecke n. Front Med (Lausanne). 2021 Nov 25;8:770381. doi: 10.3389/fmed.2021.770381. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34901085 Free PMC article.
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Körper S, Jahrsdörfer B, Corman VM, Pilch J, Wuchter P, Blasczyk R, Müller R, Tonn T, Bakchoul T, Schäfer R, Juhl D, Schwarz T, Gödecke N, Burkhardt T, Schmidt M, Appl T, Eichler H, Klüter H, Drosten C, Seifried E, Schrezenmeier H. Körper S, et al. Among authors: godecke n. Transfus Med Hemother. 2021 May;48(3):137-147. doi: 10.1159/000515610. Epub 2021 Apr 21. Transfus Med Hemother. 2021. PMID: 34177417 Free PMC article.
24 results